Vietnam approves China’s Sinopharm COVID-19 vaccine

About This Source - CGTN

This story is an English language news item from CGTN. CGTN is a Chinese state-funded broadcaster.

Recent from CGTN:

  • What’s the key to winning the global battle against COVID-19?
  • SIFF2021: The reasons we love movies
  • Live: How traditional Chinese musical instrument Guzheng is made in Lankao
  • CGTN published this video item, entitled “Vietnam approves China’s Sinopharm COVID-19 vaccine” – below is their description.

    For more:

    https://www.cgtn.com/video

    Vietnam has approved China’s Sinopharm vaccine for use against COVID-19, local media reported on Friday. The decision was signed by Deputy Minister of Health Truong Quoc Cuong, according to VnExpress. It is the third coronavirus vaccine Vietnam has approved, after AstraZeneca’s and Sputnik V.

    CGTN YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    In This Story: AstraZeneca

    AstraZeneca plc/AB (LON: AZN) is a British-Swedish multinational pharmaceutical and biopharmaceutical company with its headquarters in Cambridge, United Kingdom and Södertälje, Sweden. Its R&D is concentrated in Cambridge in United Kingdom, Södertälje in Sweden, and Maryland and Toronto in North America.

    3 Recent Items: AstraZeneca

  • What do the new loosened travel restrictions mean for fully-vaccinated Canadians and residents?
  • Biden Delays 80 Million U.S. Vaccine Shipments Until July, Psaki Says
  • Australia’s vaccine rollout to be ‘ramped up’ in second half of year as more doses arrive | 7NEWS
  • In This Story: China

    China is the third largest country in the world by area and the largest country in the world by population. Properly known as the People’s Republic of China, the political territory of the country includes the former nations of Tibet and Hong Kong. The capital is Beijing.

    7 Recent Items: China

  • What’s the key to winning the global battle against COVID-19?
  • Live: How traditional Chinese musical instrument Guzheng is made in Lankao
  • Hong Kong to shorten mandatory quarantine to 7 days for fully vaccinated residents, travellers
  • Hong Kong Apple Daily Arrests Not a Tool to Suppress Media: Carrie Lam
  • Live: Go inside the CPV air force’s former bases in NE China
  • China’s Credit Market Is Diverging: JPMorgan’s Zhang
  • Evergrande Takes on Short Sellers
  • In This Story: COVID-19

    Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

    Symptoms of coronavirus

    The main symptoms of coronavirus are:

    • a persistent new cough (non productive, dry)
    • a high temperature (e.g. head feels warm to the touch)
    • shortness of breath (if this is abnormal for the individual, or increased)

    Latest News about Covid-19

    Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

    5 Recent Items: COVID-19

  • What’s the key to winning the global battle against COVID-19?
  • Hong Kong to shorten mandatory quarantine to 7 days for fully vaccinated residents, travellers
  • One new case in Queensland as border opens to Victoria | Coronavirus | 9 News Australia
  • CO v. Mark Redwine on Trial in Murder of Son Dylan – Defense Opening Statement (Sound Boosted)
  • NSW State Budget 2020/2021 | 7NEWS
  • In This Story: Sinopharm

    China National Pharmaceutical Group Corp. known as Sinopharm is a Chinese state-owned enterprise. The corporation was the indirect major shareholder of publicly traded companies Sinopharm Group, China Traditional Chinese Medicine. Shanghai Shyndec Pharmaceutical and Beijing Tiantan Biological Products.

    2 Recent Items: Sinopharm

  • China approves Sinopharm and Sinovac jabs for emergency use for children aged 3 to 17
  • WHO-approved China-made vaccines: Impact on global COVID-19 response
  • In This Story: Sputnik V

    Gam-COVID-Vac, trade-named Sputnik V, is a COVID-19 vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology, and registered on 11 August 2020 by the Russian Ministry of Health. It has been approved for distribution in Russia.

    The phase III trial for Gam-COVID-Vac was registered on 28 August 2020, and is a randomised, double-blind, placebo-controlled, multi-centre clinical trial involving 40,000 volunteers. The phase III trial is scheduled to run until May 2021.

    On 5 December 2020, Russia began mass vaccinations in Moscow, with 70 clinics inoculating those most at risk from the virus. Health workers and teachers were said to have priority in the first mass immunisation programme. People who had received injections in the last 30 days or had respiratory diseases in the previous two weeks were excluded, as well as those with certain chronic illnesses, and pregnant and breastfeeding women.

    2 Recent Items: Sputnik V

  • Biden announces US will donate 500 million Covid-19 vaccines
  • President Putin’s meeting with international investors and international Sputnik V producers [TAPE]
  • In This Story: Vietnam

    Vietnam is a Southeast Asian country known for its beaches, rivers, Buddhist pagodas and bustling cities. Hanoi, the capital, pays homage to the nation’s iconic Communist-era leader, Ho Chi Minh, via a huge marble mausoleum. Ho Chi Minh City (formerly Saigon) has French colonial landmarks, plus Vietnamese War history museums and the Củ Chi tunnels, used by Viet Cong soldiers.

    5 Recent Items: Vietnam

  • Vietnam’s pangolin defender wins top environmental prize
  • China, Asean diplomats gather in Chongqing to mark 30th anniversary of dialogue
  • China-ASEAN diplomats gather in Chongqing to mark 30th anniversary
  • Vietnam cases surge: Lockdowns enforced as millions tested
  • Vaccination gaps enable virus mutations | COVID-19 Special
  • Leave a Comment